Role of lipid mediators in host resistance to Mycobacterium tuberculosis

脂质介质在宿主对结核分枝杆菌的抵抗中的作用

基本信息

  • 批准号:
    7314285
  • 负责人:
  • 金额:
    $ 41.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-15 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (Mtb) grows in human macrophages, the principal host cell, where it occupies a niche allowing it to replicate without being recognized by the host. Attenuated Mtb induce apoptosis of the host macrophages resulting in containment of the bacilli and to their elimination by phagocytes. A critical property of virulent Mtb is the induction of necrosis characterized by plasma membrane lysis and release of the bacilli into the intercellular space leading to spread of the infection. We found that induction of necrosis is the consequence of mitochondria! inner membrane perturbation leading to mitochondrial permeability transition. We detected further that the lipid mediators prostaglandin E2 and lipoxin A4 induce and interfere with the perturbation of the mitochondrial inner membrane resulting either in apoptosis or necrosis, respectively. PGE2 is also essential for the initiation of membrane repair mechanisms in the infected macrophages required for the establishment of apoptosis which is suppressed in macrophages infected with virulent Mtb. We could recently show identical results using murine macrophages. Because apoptosis is associated with anti-mycobacterial activity, in vitro and in vivo studies using mice with gene deletions relating to prostanoid and eicosanoid synthesis will be performed. Mice deficient in PGE2 production (prostaglandin synthase -/-, COX2 -/-, PGE2 receptor production (EP1 - 5), and in the production of LXA4 (5-LO and 15- LO-/-) will be used in the in vitro and in vivo experiments. We will investigate in vitro mitochondrial inner membrane damage related to necrosis, cytochrome c release necessary for the induction of apoptosis, and membrane repair mechanisms necessary for the generation of apoptotic cells in infected macrophages of WT and of the various -/- murine models mentioned above. These experiments will be paralleled by in vivo studies involving WT and the various lipid mediator and EP - / - mice using a novel model of bacterial delivery to pinpoint the role of apoptosis and necrosis in innate and clonal defenses against TB assessing pathology and bacterial burden in lung and spleen. The studies proposed in this application will provide critical new information about the interactions between Mycobacterium tuberculosis and the host macrophage, and about the early defense against TB.
描述(申请人提供):结核分枝杆菌(Mtb)生长在人巨噬细胞(主要宿主细胞)中,在那里它占据了一个小生境,使其能够复制而不被宿主识别。减毒的Mtb诱导宿主巨噬细胞的凋亡,导致细菌的遏制和它们被吞噬细胞消除。毒性Mtb的一个关键特性是诱导坏死,其特征在于质膜溶解和杆菌释放到细胞间隙中,导致感染扩散。我们发现,诱导坏死是线粒体的后果!内膜扰动导致线粒体通透性转变。我们进一步检测到,脂质介质前列腺素E2和脂氧素A4诱导和干扰线粒体内膜的扰动,导致细胞凋亡或坏死,分别。PGE 2对于启动感染的巨噬细胞中的膜修复机制也是必需的,所述膜修复机制是建立细胞凋亡所需的,所述细胞凋亡在用毒性Mtb感染的巨噬细胞中被抑制。我们最近可以用鼠巨噬细胞显示相同的结果。由于细胞凋亡与抗分枝杆菌活性相关,因此将使用与前列腺素和类花生酸合成相关的基因缺失的小鼠进行体外和体内研究。将在体外和体内实验中使用PGE 2产生(前列腺素合酶-/-、COX 2-/-、PGE 2受体产生(EP 1 - 5))和LXA 4产生(5-LO和15- LO-/-)缺陷的小鼠。我们将在体外研究与坏死相关的线粒体内膜损伤,细胞色素c释放诱导凋亡所必需的,以及在WT和上述各种-/-小鼠模型的感染巨噬细胞中产生凋亡细胞所必需的膜修复机制。这些实验将通过涉及WT和各种脂质介体和EP - / -小鼠的体内研究进行验证,使用新型细菌递送模型来确定细胞凋亡和坏死在针对TB的先天性和克隆防御中的作用,评估肺和脾中的病理学和细菌负荷。本申请中提出的研究将提供有关结核分枝杆菌与宿主巨噬细胞之间相互作用以及结核病早期防御的重要新信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEINZ Gernot REMOLD其他文献

HEINZ Gernot REMOLD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEINZ Gernot REMOLD', 18)}}的其他基金

Investigating the Role of the GTPase Arl8b in Plasma Membrane Repair of Mtb-Infected Macrophages
研究 GTPase Arl8b 在 Mtb 感染的巨噬细胞质膜修复中的作用
  • 批准号:
    8892398
  • 财政年份:
    2015
  • 资助金额:
    $ 41.32万
  • 项目类别:
Investigating the Role of the GTPase Arl8b in Plasma Membrane Repair of Mtb-Infected Macrophages
研究 GTPase Arl8b 在 Mtb 感染的巨噬细胞质膜修复中的作用
  • 批准号:
    9060247
  • 财政年份:
    2015
  • 资助金额:
    $ 41.32万
  • 项目类别:
Regulation of Apoptotic Envelope Formation by MTB in the Host Macrophage
MTB 对宿主巨噬细胞中凋亡包膜形成的调节
  • 批准号:
    7523349
  • 财政年份:
    2009
  • 资助金额:
    $ 41.32万
  • 项目类别:
Regulation of Apoptotic Envelope Formation by MTB in the Host Macrophage
MTB 对宿主巨噬细胞中凋亡包膜形成的调节
  • 批准号:
    7847606
  • 财政年份:
    2009
  • 资助金额:
    $ 41.32万
  • 项目类别:
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
脂质介质在宿主对结核分枝杆菌的抵抗中的作用
  • 批准号:
    7630593
  • 财政年份:
    2007
  • 资助金额:
    $ 41.32万
  • 项目类别:
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
脂质介质在宿主对结核分枝杆菌的抵抗中的作用
  • 批准号:
    8094331
  • 财政年份:
    2007
  • 资助金额:
    $ 41.32万
  • 项目类别:
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
脂质介质在宿主对结核分枝杆菌的抵抗中的作用
  • 批准号:
    7446613
  • 财政年份:
    2007
  • 资助金额:
    $ 41.32万
  • 项目类别:
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
脂质介质在宿主对结核分枝杆菌的抵抗中的作用
  • 批准号:
    7864117
  • 财政年份:
    2007
  • 资助金额:
    $ 41.32万
  • 项目类别:
A Novel Mechanism of Innate Immunity Against TB
抗结核病的先天免疫新机制
  • 批准号:
    6474357
  • 财政年份:
    2002
  • 资助金额:
    $ 41.32万
  • 项目类别:
A Novel Mechanism of Innate Immunity Against TB
抗结核病的先天免疫新机制
  • 批准号:
    6854507
  • 财政年份:
    2002
  • 资助金额:
    $ 41.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了